Analysis and clinical implications of p53 gene mutations and human papillomavirus type 16 and 18 infection in primary adenocarcinoma of the uterine cervix

American Journal of Pathology

Volumn 152, Issue 4, 1998, Pages 1057-1063

  Tenti, Patrizia ^a   Pavanello, Sofia ^a,b   Padovan, Laura ^a   Spinillo, Arsenio ^a   Vesentini, Nicoletta ^a   Zappatore, Rita ^a   Migliora, Paola ^a   Zara, Carlo ^a   Ranzani, Guglielmina N ^a   Carnevali, Luciano ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; PROTEIN P53; VIRUS DNA;

ADENOCARCINOMA; ADULT; AGE; AGED; ARTICLE; CANCER GRADING; CANCER STAGING; DENATURING GRADIENT GEL ELECTROPHORESIS; DNA SEQUENCE; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL; TUMOR SUPPRESSOR GENE; UTERINE CERVIX CARCINOMA; VIRUS INFECTION; WART VIRUS;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; DNA, VIRAL; FEMALE; GENES, P53; HUMANS; MIDDLE AGED; MUTATION; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PROGNOSIS; SURVIVAL ANALYSIS; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS;

EID: 0031922064     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Soussi T, Legros Y, Lubin R, Ory K, Schlichtholz B: Multifactorial analysis of p53 alteration in human cancer: a review. Int J Cancer 1994, 57:1-9
2. Greenblatt MS, Bennett WP, Hollstein M, Harris CC: Mutation in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 1994, 54:4855-4878
3. Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM: The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 1990, 63:1129-1136
4. Crook T, Tidy JA, Vousden KH: Degradation of p53 can be targeted by HPV E6 sequences distinct from those required for p53 binding and trans-activation. Cell 1991, 67:547-556
5. Crook T, Fisher C, Masterson PJ, Vousden KH: Modulation of transcriptional regulatory properties of p53 by HPV E6. Oncogene 1994, 9:1225-1230
6. Gu Z, Pirn D, Labrecque S, Banks L, Matlashewski G: DNA damage induced p53 mediated transcription is inhibited by human papillomavirus type 18 E6. Oncogene 1994, 9:629-633
7. Pim D, Storey A, Thomas M, Massimi P, Banks L: Mutational analysis of HPV-18 E6 identifies domains required for p53 degradation in vitro, abolition of p53 transactivation in vivo and immortalisation of primary BMK cells. Oncogene 1994, 9:1869-1876
8. Crook T, Wrede D, Tidy JA, Mason WP, Evans DJ, Vousden KH: Clonal p53 mutations in primary cervical cancer: association with human papillomavirus-negative tumours. Lancet 1992, 339:1070-1073
9. Fujita M, Inoue M, Tanizawa O, Iwamoto S, Enomoto T: Alteration of the p53 gene in human primary cervical carcinoma with and without human papillomavirus infection. Cancer Res 1992, 52:5323-5328
10. Park DJ, Wilczynski SP, Paquette RL, Miller CW, Koeffler HP: p53 mutations in HPV-negative cervical carcinoma. Oncogene 1994, 9:205-210
11. Milde-Langosch K, Albrecht K, Joram S, Schlechte H, Giessing M, Löning T: Presence and persistence of HPV infection and p53 mutation in cancer of the cervix uteri and the vulva. Int J Cancer 1995, 63:639-645
12. Kim JW, Cho YH, Lee CG, Kim JH, Kim HK, Kim EJ, Han KT, Namkoong SE: Human papillomavirus infection and TP53 gene mutation in primary cervical carcinoma. Acta Oncol 1997, 36:295-300
13. Jiko K, Tsuda H, Sato S, Hirohashi S: Pathogenetic significance of p53 and c-Ki-ras gene mutations and human papillomavirus DNA integration in adenocarcinoma of the uterine cervix and uterine isthmus. Int J Cancer 1994, 59:601-606
14. Kurman RJ (Ed): Blaustein's Pathology of the Female Genital Tract. Berlin, Springer-Verlag, 1994, pp 300-309
15. Borresen A, Hovig E, Smith-Sorensen B, Malkin D, Lystad S, Andersen TI, Nesland JM, Isselbacher KJ, Friend SH: Constant denaturant gel electrophoresis as a rapid screening technique for p53 mutations. Proc Natl Acad Sci USA 1991, 88:8405-8409
16. Myers RM, Fisher SG, Maniatis T, Lerman L: Modification of the melting properties of duplex DNA by attachment of GC DNA sequence as determined by denaturing gradient gel electrophoresis. Nucleic Acids Res 1985, 13:3111-3129
17. Sheffield VC, Cox DR, Lerman LS, Myers RM: Attachment of a 40-base-pair G+C-rich sequence (GC-clamp) to genomic DNA fragments by the polymerase chain reaction results in improved detection of single base changes. Proc Natl Acad Sci USA 1989, 86:232-236
18. Sheffield VC, Fishman GA, Beck JS, Kimura AE: Identification of novel rhodopsin mutations associated with retinitis pigmentosa by GC-clamped denaturing gradient gel electrophoresis. Am J Hum Genet 1991, 49:699-706
19. Pellegata NS, Losekoot M, Fodde R, Pugliese V, Saccomanno S, Renault B, Bernini LF, Ranzani GN: Detection of K-ras mutation by denaturing gradient gel electrophoresis (DGGE): a study on pancreatic cancer. Anticancer Res 1992, 12:1731-1736
20. Myers RM, Maniatis T, Lerman LS: Detection and localization of single base changes by denaturing gradient gel electrophoresis. Methods Enzymol 1987, 155:501-517
21. Sanger F, Nicklen S, Coulson AR: DNA sequencing with chain terminating inhibitors. Proc Natl Acad Sci USA 1977, 74:5463-5467
22. Tenti P, Romagnoli S, Silini E, Zappatore R, Spinillo A, Giunta P, Cappellini A, Vesentini N, Zara C, Carnevali L: Human papillomavirus types 16 and 18 infection in infiltrating adenocarcinoma of the cervix: PCR analysis of 138 cases and correlation with histologic type and grade. Am J Clin Pathol 1996, 106:52-56
23. Manos MM, Wright DK, Lewis AJ, Broker TR, Wolinsky SM: The use of polymerase chain reaction amplification for the detection of genital papillomavirus Molecular Diagnostics of Human Cancer. Edited by Furth M, Greaves M. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory Press, 1989, pp 209-214
24. Brand E, Berek JS, Hacker NF: Controversies in the management of cervical adenocarcinoma. Obstet Gynecol 1988, 71:261-269
25. Johnson TL, Kim W, Plieth A, Sarkar FH: Detection of HPV 16/18 DNA in cervical adenocarcinoma using polymerase chain reaction (PCR) methodology. Mod Pathol 1992, 5:35-40
26. Stoler M, Greer C, Shick E, Kurman R, Bonfiglio T, Kadish A, Wheeler C, Manos M: The association and type distribution of HPVs in adenocarcinoma of the uterine cervix. Mod Pathol 1992, 5:69A.
27. Milde-Langosch K, Schreiber C, Becker G, Löning T, Stegner HE: Human papillomavirus detection in cervical adenocarcinoma by polymerase chain reaction. Hum Pathol 1993, 24:590-594
28. Duggan MA, McGregor SE, Benoit JL, Inoue M, Nation J, Stuart GCE: The human papillomavirus status of invasive cervical adenocarcinoma: a clinicopathological and outcome analysis. Hum Pathol 1995, 26:319-325
29. Zur Hausen H: Human papillomaviruses in the pathogenesis of anogenital cancer. Virology 1991, 184:9-13
30. Bos JL: ras oncogenes in human cancer: a review. Cancer Res 1989, 49:4682-4689
31. Tenti P, Romagnoli S, Silini E, Pellegata NS, Zappatore R, Spinillo A, Zara C, Ranzani GN, Carnevali L: Analysis and clinical implications of K-ras gene mutations and infection with human papillomavirus types 16 and 18 in primary adenocarcinoma of the uterine cervix. Int J Cancer 1995, 64:9-13
32. Busby-Eazle RMC, Steel CM, Williams ARW, Cohen B, Bird CC: Papillomaviruses, p53 and cervical cancer. Lancet 1992, 339:1350
33. Tsuda H, Hiroashi S: Frequent occurrence of p53 gene mutations in uterine cancers at advanced clinical stage and with aggressive histological phenotypes. Jpn J Cancer Res 1992, 83:1184-1191
34. Crook T. Vousden KH: Properties of p53 mutations detected in primary and secondary cervical cancers suggest mechanisms of metastasis and involvement of environmental carcinogens. EMBO J 1992, 11:3935-3940
35. Sherman ME, Bur ME, Kurman RJ: p53 in endometrial cancer and its putative precursors: evidence for diverse pathways of tumorigenesis. Hum Pathol 1995, 26:1268-1274
36. Hollstein M, Sidransky D, Vogelstein B, Harris CC: p53 mutations in human cancers. Science 1991, 253:49-53